Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Ottawa biotech lab gets $56M shot in the arm for COVID vaccine research
Variation Biotechnologies is working with the National Research Council to create a vaccine that would target the novel coronavirus as well as other deadly viruses.
Ottawa research lab partners with NRC to develop COVID vaccine
An Ottawa-born pharmaceutical company is teaming up with the National Research Council in a bid to develop a vaccine that will target COVID-19 as well
Get up-to-date news about the companies, people and issues that impact businesses in Ottawa and beyond.
Sponsored